significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
Published 7 years ago • 389 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
2:42
phase ii results for abemaciclib in pretreated hr /her2-negative breast cancer
-
5:12
monarch 2: abemaciclib added to fulvestrant shows os benefit in hr /her2- advanced breast cancer
-
1:13
overall survival data of the monarch-2 trial in hr /her2- breast cancer
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
2:58
dr. goetz discusses a secondary analysis of the monarch trials in breast cancer
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
0:52
exploring abemaciclib for the treatment of brain metastases in hr /her2- breast cancer
-
1:39
abemaciclib for hr /her2- advanced or metastatic breast cancer
-
1:33
ongoing trial of abemaciclib and pembrolizumab in hr /her2-negative breast cancer
-
2:26
updated results of the monaleesa-2 trial in hr /her2- breast cancer
-
5:34
monarch 2: overall survival of abemaciclib plus fulvestrant in hr , her2- advanced breast cancer
-
4:19
abemaciclib plus nsai for hr , her2- advanced breast cancer - monarch 3 interim data
-
5:06
safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
-
1:46
comment: monarch 3 trial: abemaciclib for advanced breast cancer
-
1:18
findings with abemaciclib plus tamoxifen in advanced breast cancer
-
1:48
natalee and monarche: ribociclib and abemaciclib in hr /her2- breast cancer
-
1:26
monarche: investigating adjuvant abemacicilib for high-risk hr breast cancer
-
2:27
results of the monaleesa-2 study in advanced breast cancer
-
1:13
erika hamilton, md, considers the significance of the monarche study & the use of abemaciclib